Skip to main content

Table 2 Spectrum of DV by gene, personal and family history of HBOC and LS

From: Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory

Gene Set

Gene

Total number of cases with DV

Individuals with Personal Historyc

Individuals with Family Historyc

HBOC

LS

HBOC

LS

BRCA

BRCA1

10

5

1

10

5

BRCA2 a

10

3

0

8

6

Lynch

MSH2

4

1

2

3

4

MSH6 a

3

0

1

0

2

PMS2 a

7

1

0

4

3

High Risk

CDH1

1

0

0

1

1

APC

1

0

0

0

1

MUTYH b

14

5

1

12

11

Moderate – Low Risk

ATM

8

5

0

5

7

BARD1 a

1

0

0

0

0

BRIP1 a

5

0

0

4

2

CHEK2 a

9

3

3

7

3

NBN

3

0

0

2

2

PALB2

4

0

1

3

2

  1. aNo Clinical data was provided for 1 individual with DV detected in BARD1, BRCA2, BRIP1, CHEK2, MSH6 and 2 individuals with a DV detected in PMS2
  2. bOne individual was biallelic for a DV in MUTYH, and two MUTYH DV carriers harbored a second DV in a different gene on the panel
  3. cAs ovarian cancer is a common clinical feature of both HBOC and LS, patients with ovarian cancer were included in both these categories